Sartorius Stedim (DIM) | Financial Analysis & Statements
Sartorius Stedim Biotech S.A. | Large-cap | Healthcare
Sartorius Stedim Biotech S.A. | Large-cap | Healthcare
Financial Overview
Latest Annual: 2024Income Metrics
Revenue
2.8B
Gross Profit
1.2B
43.41%
Operating Income
395.2M
14.22%
Net Income
178.5M
6.42%
EPS (Diluted)
€1.81
Balance Sheet Metrics
Total Assets
8.3B
Total Liabilities
4.2B
Shareholders Equity
4.0B
Debt to Equity
1.05
Cash Flow Metrics
Operating Cash Flow
618.7M
Free Cash Flow
475.3M
Revenue & Profitability Trend
Sartorius Stedim Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 2.8B | 2.8B | 3.5B | 2.9B | 1.9B |
| Cost of Goods Sold | 1.6B | 1.5B | 1.7B | 1.3B | 906.8M |
| Gross Profit | 1.2B | 1.2B | 1.8B | 1.6B | 1.0B |
| Operating Expenses | 825.0M | 771.8M | 772.6M | 674.0M | 503.9M |
| Operating Income | 395.2M | 470.5M | 1.1B | 883.0M | 503.4M |
| Pre-tax Income | 219.2M | 401.1M | 1.1B | 646.7M | 460.7M |
| Income Tax | 40.7M | 89.0M | 250.5M | 232.4M | 122.1M |
| Net Income | 178.5M | 312.1M | 879.9M | 414.3M | 338.6M |
| EPS (Diluted) | €1.81 | €3.36 | €9.51 | €4.50 | €3.64 |
Income Statement Trend
Sartorius Stedim Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | 1.7B | 1.4B | 1.7B | 1.5B | 873.9M |
| Non-Current Assets | 6.5B | 6.3B | 3.4B | 2.5B | 2.0B |
| Total Assets | 8.3B | 7.7B | 5.1B | 4.0B | 2.9B |
| Liabilities | |||||
| Current Liabilities | 938.8M | 937.3M | 1.0B | 1.0B | 567.8M |
| Non-Current Liabilities | 3.3B | 4.1B | 1.5B | 1.2B | 827.9M |
| Total Liabilities | 4.2B | 5.1B | 2.6B | 2.2B | 1.4B |
| Equity | |||||
| Total Shareholders Equity | 4.0B | 2.7B | 2.5B | 1.7B | 1.5B |
Balance Sheet Composition
Sartorius Stedim Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 219.2M | 401.1M | 1.1B | 646.7M | 460.7M |
| Operating Cash Flow | 618.7M | 656.4M | 645.8M | 627.1M | 351.7M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Investing Cash Flow | -200.0K | -2.2B | -526.9M | -465.2M | -621.1M |
| Financing Activities | |||||
| Dividends Paid | -67.1M | -132.7M | -116.1M | -62.7M | -31.3M |
| Financing Cash Flow | 262.7M | 2.1B | 235.8M | -68.3M | 242.9M |
| Free Cash Flow | 475.3M | 272.8M | 181.7M | 377.9M | 416.9M |
Cash Flow Trend
Sartorius Stedim Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
92.35
Forward P/E
45.21
Price to Book
4.77
Price to Sales
6.63
PEG Ratio
45.21
Profitability Ratios
Profit Margin
7.15%
Operating Margin
18.98%
Return on Equity
5.25%
Return on Assets
3.19%
Financial Health
Current Ratio
1.84
Debt to Equity
73.17
Beta
0.93
Per Share Data
EPS (TTM)
€2.11
Book Value per Share
€40.84
Revenue per Share
€29.53
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| dim | 19.0B | 92.35 | 4.77 | 5.25% | 7.15% | 73.17 |
| Crédit Agricole S.A | 516.5B | 0.87 | 0.16 | 23.53% | 51.63% | 0.00 |
| Crédit Agricole S.A | 285.0B | 89.23 | - | 0.00% | 0.00% | - |
| Credit Agricole S.A | 284.7B | 89.15 | - | 0.00% | 0.00% | - |
| Credit Agricole S.A | 285.3B | 89.31 | - | 0.00% | 0.00% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.